-
EP3958968
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP3958968
| EP3958968 - A 7H-PYRROLO[2,3-D]PYRIMIDINE JAK-INHIBITOR [Right-click to bookmark this link] | Status | Examination is in progress Status updated on 21.09.2023 Database last updated on 11.04.2026 | |
| Former | Request for examination was made Status updated on 28.01.2022 | ||
| Former | The international publication has been made Status updated on 31.10.2020 | ||
| Former | unknown Status updated on 18.05.2020 | Most recent event Tooltip | 24.04.2025 | New entry: Renewal fee paid | Applicant(s) | For all designated states ELANCO US INC. 2500 Innovation Way Greenfield, IN 46140 / US | [2022/09] | Inventor(s) | 01 /
HU, Jingdan c/o Elanco Animal Health 2500 Innovation Way Greenfield, Indiana 46140 / US | 02 /
WOODS, Timothy Andrew c/o Elanco Animal Health 2500 Innovation Way Greenfield, Indiana 46140 / US | [2022/09] | Representative(s) | Cohausz & Florack Patent- & Rechtsanwälte Partnerschaftsgesellschaft mbB Postfach 10 18 30 40009 Düsseldorf / DE | [N/P] |
| Former [2022/09] | Tier 1 Patents Bayer Animal Health GmbH Bldg. 6700 Alfred-Nobel-Straße 50 40789 Monheim am Rhein / DE | Application number, filing date | 20724705.7 | 22.04.2020 | [2022/09] | WO2020US29283 | Priority number, date | US201962837972P | 24.04.2019 Original published format: US 201962837972 P | [2022/09] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2020219524 | Date: | 29.10.2020 | Language: | EN | [2020/44] | Type: | A1 Application with search report | No.: | EP3958968 | Date: | 02.03.2022 | Language: | EN | The application published by WIPO in one of the EPO official languages on 29.10.2020 takes the place of the publication of the European patent application. | [2022/09] | Search report(s) | International search report - published on: | EP | 29.10.2020 | Classification | IPC: | A61P17/00, C07D487/04, A61K31/519 | [2022/09] | CPC: |
C07D487/04 (EP,KR,US);
A61K31/519 (KR);
A61P17/00 (EP,KR,US);
A61P17/04 (KR);
A61P29/00 (KR);
A61P37/08 (US);
C07B2200/13 (KR,US)
(-)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2022/09] | Title | German: | 7H-PYRROLO[2,3-D]PYRIMIDIN-JAK-HEMMER | [2022/09] | English: | A 7H-PYRROLO[2,3-D]PYRIMIDINE JAK-INHIBITOR | [2022/09] | French: | INHIBITEUR DE JAK 7H-PYRROLO[2,3-D]PYRIMIDINE | [2022/09] | Entry into regional phase | 24.11.2021 | National basic fee paid | 24.11.2021 | Designation fee(s) paid | 24.11.2021 | Examination fee paid | Examination procedure | 24.11.2021 | Examination requested [2022/09] | 24.11.2021 | Date on which the examining division has become responsible | 17.06.2022 | Amendment by applicant (claims and/or description) | 20.09.2023 | Despatch of a communication from the examining division (Time limit: M04) | 29.01.2024 | Reply to a communication from the examining division | Fees paid | Renewal fee | 21.03.2022 | Renewal fee patent year 03 | 21.03.2023 | Renewal fee patent year 04 | 18.03.2024 | Renewal fee patent year 05 | 23.04.2025 | Renewal fee patent year 06 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [XD] WO2009114512 (INCYTE CORP et al.) | by applicant | WO2009114512 | JOURNAL OF PHARMACEUTICAL SCIENCE, vol. 66, 1977, pages 2 - 19 | THE UNITED STATES PHARMACOPOEIA #24, NATIONAL FORMULARY #19, 2000, pages 1843 - 1844 | T. W. GREENEP. G. M. WUTS: "Protective Groups in Organic Synthesis", 1999, WILEY & SONS, INC. |